Atossa Genetics Inc. | Key People and Executives
Steven C. Quay
Chairman, President & Chief Executive Officer
Richard I. Steinhart
Independent Director
Gregory L. Weaver
Independent Director
H. Lawrence Remmel
Independent Director
Stephen J. Galli
Independent Director
Steven C. Quay
Chairman, President & Chief Executive Officer
Kyle Guse
CFO, Secretary & Principal Accounting Officer
Janet Rose Rea
VP-Regulatory Affairs, Quality & Clinical Affairs
Richard I. Steinhart
Independent Director
Gregory L. Weaver
Independent Director
H. Lawrence Remmel
Independent Director
Stephen J. Galli
Independent Director
| Address |
107 Spring Street
Seattle Washington 98104
United States
|
|
Employees
|
- |
| Website |
http://www.atossagenetics.com |
| Updated |
07/08/2019 |
| Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. |
